Online Supplement for:Questioning the renoprotective role of L-type calcium channel blockers in chronic kidney disease using physiological modelingKyle H. Moore and John S. ClemmerDepartment of Physiology and Biophysics, Center for Computational Medicine, University of Mississippi Medical Center, Jackson, MS 39216Materials included:1) Experimental Protocols2) Supplementary figures and tables3) Raw model outputs4) List of model variables and files<br
<b><i>Background/Aims:</i></b> Ferric citrate hydrate (JTT-751) is being developed as a treatment fo...
Background: Mineral and bone disorder (MBD) is common in patients with chronic kidney disease (CKD),...
The advancing chronic renal failure is at most the consequence of secondary haemodynamic and metabol...
There has been a growing number of evidence that calcium antagonists provide a salutary effects in p...
Supplemental material, Supplement_2 for An Adjustable Dalteparin Sodium Dose Regimen for the Prevent...
Supplemental material, Supplement_1 for An Adjustable Dalteparin Sodium Dose Regimen for the Prevent...
<p>Supplemental Material, Suppl_table_1 for Effects of Long- and Intermediate-Acting Dihydropyridine...
To test the hypothesis that thiazide-type diuretics effectively lower blood pressure (BP) in moderat...
Figure S2. Supplementary documents describing parameter determination in detail. (DOC 128 kb
Background/Aims: Dietary potassium (K+) has beneficial effects on blood pressure and cardiovascular ...
Supplemental material, Supplement_3 for An Adjustable Dalteparin Sodium Dose Regimen for the Prevent...
CITATION: Mugendi, G. A. et al. 2014. Calcium channel blockers for people with chronic kidney diseas...
Supplemental material, Supplementary_Figure_1,2_and_3_(1) for Kidney Function, ACE-Inhibitor/Angiote...
Figure S1. Implemented MSM-dg flowchart. Uniform random numbers were used for determination of live ...
Background: Management of chronic kidney disease (CKD) patients includes efforts directed toward mod...
<b><i>Background/Aims:</i></b> Ferric citrate hydrate (JTT-751) is being developed as a treatment fo...
Background: Mineral and bone disorder (MBD) is common in patients with chronic kidney disease (CKD),...
The advancing chronic renal failure is at most the consequence of secondary haemodynamic and metabol...
There has been a growing number of evidence that calcium antagonists provide a salutary effects in p...
Supplemental material, Supplement_2 for An Adjustable Dalteparin Sodium Dose Regimen for the Prevent...
Supplemental material, Supplement_1 for An Adjustable Dalteparin Sodium Dose Regimen for the Prevent...
<p>Supplemental Material, Suppl_table_1 for Effects of Long- and Intermediate-Acting Dihydropyridine...
To test the hypothesis that thiazide-type diuretics effectively lower blood pressure (BP) in moderat...
Figure S2. Supplementary documents describing parameter determination in detail. (DOC 128 kb
Background/Aims: Dietary potassium (K+) has beneficial effects on blood pressure and cardiovascular ...
Supplemental material, Supplement_3 for An Adjustable Dalteparin Sodium Dose Regimen for the Prevent...
CITATION: Mugendi, G. A. et al. 2014. Calcium channel blockers for people with chronic kidney diseas...
Supplemental material, Supplementary_Figure_1,2_and_3_(1) for Kidney Function, ACE-Inhibitor/Angiote...
Figure S1. Implemented MSM-dg flowchart. Uniform random numbers were used for determination of live ...
Background: Management of chronic kidney disease (CKD) patients includes efforts directed toward mod...
<b><i>Background/Aims:</i></b> Ferric citrate hydrate (JTT-751) is being developed as a treatment fo...
Background: Mineral and bone disorder (MBD) is common in patients with chronic kidney disease (CKD),...
The advancing chronic renal failure is at most the consequence of secondary haemodynamic and metabol...
DOI
Add to ORKG